Tokyo, Sept. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059009) titled 'Development and Evaluation of an AI-Based Online Cancer Consultation System' on Sept. 5.
Study Type:
Observational
Primary Sponsor:
Institute - Hamamatsu University School of Medicine
Condition:
Condition - Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to evaluate the usefulness of a hybrid online cancer consultation system by comparing responses generated through three approaches using a dedicated web-based application: (i) generative AI, (ii) healthcare professionals, and (iii) a hybrid model combining AI and healthcare professionals. Both patients and healthcare professionals will assess these responses
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
=18 years
Key exclusion criteria - Individuals without cancer and their family members
Individuals unable to use a personal computer or smartphone for online consultation
Target Size - 100
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 03 Month 10 Day
Date of IRB - 2025 Year 07 Month 28 Day
Anticipated trial start date - 2025 Year 07 Month 28 Day
Last follow-up date - 2030 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067489
Disclaimer: Curated by HT Syndication.
